HOME >> BIOLOGY >> NEWS
Yale scientist honored with Keio University Medical Science Prize

New Haven, Conn. -- Thomas A. Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 11th Keio Medical Science Prize in a ceremony and commemorative symposium on November 1 at Keio University in Tokyo, Japan.

The award, made to researchers in recognition of their outstanding achievements in the fields of medical or life sciences, is the only prize of its kind awarded by a Japanese University. It included an honorarium of 20 million yen, a certificate of merit in recognition of his outstanding achievement on the structural basis of the large ribosomal subunit function and drug development, and a commemorative symposium.

Steitz was honored for research he led that in 2000 produced the first X-ray crystallographic imaging of the large ribosomal subunit. From this work, he and his collaborators have gone on to identify the structural basis of antibiotic drug function and resistance associated with this fundamental cellular structure. They have founded Rib-X, a company developing a new family of antibiotics intended to combat bacteria that have become drug-resistant.

It is surprising how rapidly our basic research on what was then the central dogma of biology, was able to move into the realm of health application, said Steitz. We had been studying the fundamentals of DNA replication, RNA transcription and reverse transcription, and protein synthesis. The ability to visualize this cellular machine gave us a whole new way to look at how bacteria develop resistance to antibiotics.

When antibiotics work they cure the patient, said Steitz. Many antibiotics work by blocking a ribosome function that stops bacteria from propagating by interfering with their ability to make proteins. The work of Steitz and his Yale colleague Peter B. Moore, Sterling Professor of Chemistry, shed light on the specific molecular interactions involved between antibiotic and ribosome, and then further the on the molecul
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
22-Nov-2006


Page: 1 2

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. UK scientists working to help cut ID theft
3. Smithsonian scientists show differing patterns of rainforest biodiversity
4. Weizmann Institute scientists discover a control mechanism for metastasis
5. Cornell scientists link E. coli bacteria to Crohns disease
6. UCLA scientists produce functioning neurons from human embryonic stem cells
7. ASBMB taps 8 scientists and 1 politician for top awards
8. UF, French scientists seek test to detect gene doping in athletes
9. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
10. Universes stringy birth revealed by young Czech scientist in EURYI winning project
11. Forsyth scientists gain new understanding of adult stem cell regulation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... FREDERICK, Md. (PRWEB) , ... July 30, 2020 ... ... Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & ... goal of this project is to develop, optimize, and scale-up a highly efficient ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... today announced that the launch of a new clinical diagnostics immuno-oncology ... the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. (“Lumeda”), ... announced the company has entered a license agreement with Roswell Park Comprehensive Cancer ... exclusive rights to Roswell Park intellectual property surrounding a novel medical device and ...
Breaking Biology Technology:
Cached News: